LongBio Pharma Releases Updated Board Composition and Committee Assignments

Bulletin Express06-04

LongBio Pharma (Suzhou) Co., Ltd. announced the latest composition of its Board of Directors and detailed committee roles, effective 4 June 2026.

The 11-member Board is led by Executive Director Dr. Liu Heng, who also serves as Chairperson of the Nomination Committee. Executive Directors include Dr. Sun Bill Nai-chau and Mr. Xie Ming.

Non-executive Directors comprise Mr. Lin Jian, Ms. Gu Qin, Dr. Xue Di and Dr. Chen Kan.

Independent Non-executive Directors (INEDs) are Mr. Siu Paul Yu Hay, Mr. Ruan Tim, Mr. Yang Chun and Mr. Zhou Guofang, providing external oversight across the Board and its committees.

Committee leadership and membership are as follows: • Audit Committee: Chaired by INED Mr. Siu Paul Yu Hay; members include Mr. Xie Ming and Mr. Lin Jian. • Remuneration Committee: Chaired by INED Mr. Yang Chun; members are Ms. Gu Qin and Mr. Ruan Tim. • Nomination Committee: Chaired by Dr. Liu Heng; members include Mr. Siu Paul Yu Hay, Mr. Ruan Tim, Mr. Yang Chun and Mr. Zhou Guofang.

The announcement underscores LongBio Pharma’s commitment to balanced governance, combining executive insight with independent oversight through its committee structure.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1188119003?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-04 06:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1188119003","market":"us","top_or_hot":-1,"title":"LongBio Pharma Releases Updated Board Composition and Committee Assignments","media":"Bulletin Express","content":"<p>LongBio Pharma (Suzhou) Co., Ltd. announced the latest composition of its Board of Directors and detailed committee roles, effective 4 June 2026.</p>\n<p>The 11-member Board is led by Executive Director Dr. Liu Heng, who also serves as Chairperson of the Nomination Committee. Executive Directors include Dr. Sun Bill Nai-chau and Mr. Xie Ming.</p>\n<p>Non-executive Directors comprise Mr. Lin Jian, Ms. Gu Qin, Dr. Xue Di and Dr. Chen Kan.</p>\n<p>Independent Non-executive Directors (INEDs) are Mr. Siu Paul Yu Hay, Mr. Ruan Tim, Mr. Yang Chun and Mr. Zhou Guofang, providing external oversight across the Board and its committees.</p>\n<p>Committee leadership and membership are as follows:  \n• Audit Committee: Chaired by INED Mr. Siu Paul Yu Hay; members include Mr. Xie Ming and Mr. Lin Jian.  \n• Remuneration Committee: Chaired by INED Mr. Yang Chun; members are Ms. Gu Qin and Mr. Ruan Tim.  \n• Nomination Committee: Chaired by Dr. Liu Heng; members include Mr. Siu Paul Yu Hay, Mr. Ruan Tim, Mr. Yang Chun and Mr. Zhou Guofang.</p>\n<p>The announcement underscores LongBio Pharma’s commitment to balanced governance, combining executive insight with independent oversight through its committee structure.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>LongBio Pharma Releases Updated Board Composition and Committee Assignments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLongBio Pharma Releases Updated Board Composition and Committee Assignments\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-04 06:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>LongBio Pharma (Suzhou) Co., Ltd. announced the latest composition of its Board of Directors and detailed committee roles, effective 4 June 2026.</p>\n<p>The 11-member Board is led by Executive Director Dr. Liu Heng, who also serves as Chairperson of the Nomination Committee. Executive Directors include Dr. Sun Bill Nai-chau and Mr. Xie Ming.</p>\n<p>Non-executive Directors comprise Mr. Lin Jian, Ms. Gu Qin, Dr. Xue Di and Dr. Chen Kan.</p>\n<p>Independent Non-executive Directors (INEDs) are Mr. Siu Paul Yu Hay, Mr. Ruan Tim, Mr. Yang Chun and Mr. Zhou Guofang, providing external oversight across the Board and its committees.</p>\n<p>Committee leadership and membership are as follows:  \n• Audit Committee: Chaired by INED Mr. Siu Paul Yu Hay; members include Mr. Xie Ming and Mr. Lin Jian.  \n• Remuneration Committee: Chaired by INED Mr. Yang Chun; members are Ms. Gu Qin and Mr. Ruan Tim.  \n• Nomination Committee: Chaired by Dr. Liu Heng; members include Mr. Siu Paul Yu Hay, Mr. Ruan Tim, Mr. Yang Chun and Mr. Zhou Guofang.</p>\n<p>The announcement underscores LongBio Pharma’s commitment to balanced governance, combining executive insight with independent oversight through its committee structure.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01779","symbol_name":"天辰生物-B","start_time":0,"source_url":"","article_id":"1188119003","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1188119003","pubTimestamp":1780525395,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"LongBio Pharma (Suzhou) Co., Ltd. announced the latest composition of its Board of Directors and detailed committee roles, effective 4 June 2026. The 11-member Board is led by Executive Director Dr....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01779":"天辰生物-B"},"translate_title":"LongBio Pharma发布最新董事会组成和委员会任务","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01779":1},"content_text":"LongBio Pharma (Suzhou) Co., Ltd. announced the latest composition of its Board of Directors and detailed committee roles, effective 4 June 2026.\nThe 11-member Board is led by Executive Director Dr. Liu Heng, who also serves as Chairperson of the Nomination Committee. Executive Directors include Dr. Sun Bill Nai-chau and Mr. Xie Ming.\nNon-executive Directors comprise Mr. Lin Jian, Ms. Gu Qin, Dr. Xue Di and Dr. Chen Kan.\nIndependent Non-executive Directors (INEDs) are Mr. Siu Paul Yu Hay, Mr. Ruan Tim, Mr. Yang Chun and Mr. Zhou Guofang, providing external oversight across the Board and its committees.\nCommittee leadership and membership are as follows:  \n• Audit Committee: Chaired by INED Mr. Siu Paul Yu Hay; members include Mr. Xie Ming and Mr. Lin Jian.  \n• Remuneration Committee: Chaired by INED Mr. Yang Chun; members are Ms. Gu Qin and Mr. Ruan Tim.  \n• Nomination Committee: Chaired by Dr. Liu Heng; members include Mr. Siu Paul Yu Hay, Mr. Ruan Tim, Mr. Yang Chun and Mr. Zhou Guofang.\nThe announcement underscores LongBio Pharma’s commitment to balanced governance, combining executive insight with independent oversight through its committee structure.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1188119003","isCrawlerRequest":true}